BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1539 related articles for article (PubMed ID: 20117361)

  • 1. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.
    Carey VJ; Bishop L; Laranjo N; Harshfield BJ; Kwiat C; Sacks FM
    Am J Cardiol; 2010 Sep; 106(6):757-63. PubMed ID: 20816113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid assessment, metabolic syndrome and coronary heart disease risk.
    Arsenault BJ; Després JP; Stroes ES; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
    Eur J Clin Invest; 2010 Dec; 40(12):1081-93. PubMed ID: 20701625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men.
    Abdel-Maksoud MF; Eckel RH; Hamman RF; Hokanson JE
    J Clin Lipidol; 2012; 6(4):374-81. PubMed ID: 22836075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
    Rana JS; Visser ME; Arsenault BJ; Després JP; Stroes ES; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    Int J Cardiol; 2010 Sep; 143(3):399-404. PubMed ID: 19394708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
    Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
    Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study.
    Sondermeijer BM; Rana JS; Arsenault BJ; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    Eur J Clin Invest; 2013 Oct; 43(10):1009-15. PubMed ID: 23859101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
    Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
    Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
    Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
    Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV
    Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.
    Miller M; Cannon CP; Murphy SA; Qin J; Ray KK; Braunwald E;
    J Am Coll Cardiol; 2008 Feb; 51(7):724-30. PubMed ID: 18279736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl.
    Rana JS; Liu JY; Moffet HH; Solomon MD; Go AS; Jaffe MG; Karter AJ
    Am J Cardiol; 2015 Dec; 116(11):1700-4. PubMed ID: 26428026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.